Fick versus flow: a real-time invasive cardiovascular magnetic resonance (iCMR) reproducibility study

Yousef Arar1,2, Tarique Hussain3,4,5, Riad Abou Zahr3,5

  • 1Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, TX, USA. Yousef.Arar@UTSouthwestern.edu.

Insights

Invasive cardiovascular magnetic resonance (iCMR) provides more accurate and reliable hemodynamic assessments in congenital heart disease (CHD) patients compared to traditional catheterization. This advanced imaging technique improves flow quantification for better patient management.

Area of Science:

  • Cardiology
  • Medical Imaging
  • Pediatric Medicine

Background:

  • Congenital heart disease (CHD) necessitates accurate hemodynamic assessment.
  • Cardiac catheterization and cardiovascular magnetic resonance (CMR) imaging have distinct roles.
  • Invasive CMR (iCMR) offers simultaneous hemodynamic assessment under consistent conditions, potentially improving flow quantification.

Purpose of the Study:

  • To evaluate the incremental diagnostic value of iCMR for hemodynamic assessment in CHD.
  • To compare the accuracy and reliability of flow quantification between iCMR and traditional catheterization.

Main Methods:

  • Thirty CHD subjects underwent real-time 1.5 T iCMR with passive catheter tracking for simultaneous right (RHC) and left heart catheterization (LHC).
  • Repeat iCMR and catheterization measurements were performed to assess reliability using Pearson (PCC) and concordance correlation coefficients (CCC).

Main Results:

  • iCMR successfully completed RHC and LHC in all subjects without complications.
  • iCMR-derived systemic blood flow (Qs) showed considerably higher accuracy (PCC=0.94) and reliability (CCC=0.52) than catheter-derived Qs (PCC=0.62, CCC=0.22).
  • Pulmonary blood flow (Qp) also demonstrated high accuracy with iCMR (PCC=0.96) compared to catheterization (PCC=0.89).

Conclusions:

  • iCMR provides validated and more reproducible hemodynamic assessments in the CHD population.
  • iCMR demonstrates superior test-retest reliability for systemic blood flow (Qs) measurements.
  • iCMR enhances diagnostic capabilities for CHD patients, offering more accurate flow quantification.
Abstract